179 related articles for article (PubMed ID: 33593091)
21. Efficacy and safety of endostar combined with chemoradiotherapy versus chemoradiotherapy alone in locally advanced cervical cancer: A PRISMA-compliant systematic review and meta-analysis.
Maimaitiming N; Ma X; Wei Y; Cao L; Gao Y; Zhang L
Medicine (Baltimore); 2022 Sep; 101(36):e30170. PubMed ID: 36086700
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of bevacizumab in neoadjuvant and concurrent chemoradiotherapy for refractory cervical cancer patients.
Yang H; Huang SG; Dong M; Wang X; He J; Su H; Liu C; Zhu Y; Wei L; Liu Z
Biomol Biomed; 2024 May; ():. PubMed ID: 38761408
[TBL] [Abstract][Full Text] [Related]
23. MRI Plain Scan: A Tool in the Management of Cervical Cancer during Pregnancy.
Gao F; Qian T; Sun M; Lu Y; Cheng J; Fu L
Curr Med Imaging; 2024; 20():1-8. PubMed ID: 38389369
[TBL] [Abstract][Full Text] [Related]
24. Analysis of 30 patients with persistent or recurrent squamous cell carcinoma of the cervix within one year after concurrent chemoradiotherapy.
Liu SP; Yang JX; Cao DY; Shen K
Cancer Biol Med; 2013 Dec; 10(4):227-31. PubMed ID: 24349833
[TBL] [Abstract][Full Text] [Related]
25. A Randomized Study to Evaluate Efficacy and Toxicity Profile of Paclitaxel-carboplatin as Neo-adjuvant Chemotherapy in Locally Advanced Supraglottic and Hypopharyngeal Primaries.
Vats P; Suhag V; Chakravarty N; Vashisth R; Jain M
Indian J Otolaryngol Head Neck Surg; 2023 Jun; 75(2):366-373. PubMed ID: 37275084
[TBL] [Abstract][Full Text] [Related]
26. Neuroendocrine carcinoma of vagina with prolonged survival.
Leal-Costa L; Godinho J; Simões P; Casa-Nova M
BMJ Case Rep; 2022 Oct; 15(10):. PubMed ID: 36316052
[TBL] [Abstract][Full Text] [Related]
27. Primary poorly differentiated carcinoma of the vagina with focal neuroendocrine differentiation: a tumour with aggressive behaviour.
Mai YF; Chan IS; Lai CR; Chen YJ
BMJ Case Rep; 2022 Apr; 15(4):. PubMed ID: 35396236
[TBL] [Abstract][Full Text] [Related]
28. Maintenance chemotherapy for esophageal squamous cell carcinoma after standard concurrent chemoradiotherapy: a national propensity score matching cohort study.
Tseng SW; Chen WM; Jao AT; Chen M; Shia BC; Wu SY
Am J Cancer Res; 2024; 14(5):2300-2312. PubMed ID: 38859861
[TBL] [Abstract][Full Text] [Related]
29. The impact of trans-arterial embolization on the result of chemoradiotherapy in oral cavity cancer.
Nguyen Van D; Le Van Q; Nguyen Thi Thu N; Bui Van G; Ta Van T
Ear Nose Throat J; 2024 May; 103(5):NP272-NP277. PubMed ID: 34821166
[No Abstract] [Full Text] [Related]
30. Patterns of First Recurrence and Oncological Outcomes in Locally Advanced Cervical Cancer Patients: Does Surgical Staging Play a Role?
Bebia V; Díaz-Feijoo B; Tejerizo Á; Torne A; Benito V; Hernández A; Gorostidi M; Domingo S; Bradbury M; Luna-Guibourg R; Gil-Moreno A;
Cancers (Basel); 2024 Apr; 16(7):. PubMed ID: 38611101
[TBL] [Abstract][Full Text] [Related]
31. Association of body composition and systemic inflammation for patients with locally advanced cervical cancer following concurrent chemoradiotherapy.
Li J; Niu C; Zhang L; Mu Y; Gui X
Diagn Interv Radiol; 2024 Jun; ():. PubMed ID: 38836436
[TBL] [Abstract][Full Text] [Related]
32. Pembrolizumab plus chemoradiotherapy effective in locally advanced cervical cancer.
Sidaway P
Nat Rev Clin Oncol; 2024 Jun; 21(6):402. PubMed ID: 38565936
[No Abstract] [Full Text] [Related]
33. Chemoradiotherapy-induced ACKR2
Dai D; Pei Y; Zhu B; Wang D; Pei S; Huang H; Zhu Q; Deng X; Ye J; Xu J; Chen X; Huang M; Xiao Y
Cell Rep Med; 2024 May; 5(5):101550. PubMed ID: 38723624
[TBL] [Abstract][Full Text] [Related]
34. Prognostic prediction of oxidative stress related hematological biomarkers in locally advanced cervical cancer patients undergoing chemoradiotherapy.
Wu G; Gu M; Zhu J; Gu R; Yang B; Ji S; Zhao Y; Gu K
Biomarkers; 2024 May; ():1-10. PubMed ID: 38767430
[TBL] [Abstract][Full Text] [Related]
35. A systematic review of stage IVA cervical cancer treatment: Challenges in the management of an understudied group.
Hunsberger KS; Treiman S; Monk BJ; Tewari KS; Taunk NK; Chase DM
Gynecol Oncol; 2024 May; 187():120-127. PubMed ID: 38759518
[TBL] [Abstract][Full Text] [Related]
36. Acute Diabetes-Related Complications in Patients Receiving Chemoradiotherapy for Head and Neck Cancer.
Mellor R; Girgis CM; Rodrigues A; Chen C; Cuan S; Gambhir P; Perera L; Veness M; Sundaresan P; Gao B
Curr Oncol; 2024 Feb; 31(2):828-838. PubMed ID: 38392055
[TBL] [Abstract][Full Text] [Related]
37. Correlation of maintenance chemotherapy and improved survival in patients with locally advanced unresectable pancreatic head adenocarcinoma receiving neoadjuvant chemotherapy and concurrent chemoradiotherapy.
Tseng SW; Chen WM; Shia BC; Chen MC; Wu SY
Am J Cancer Res; 2024; 14(5):2313-2325. PubMed ID: 38859863
[TBL] [Abstract][Full Text] [Related]
38. Risk Prediction Model for Radiation-induced Dermatitis in Patients with Cervical Carcinoma Undergoing Chemoradiotherapy.
Yang H; Zhang Y; Heng F; Li W; Feng Y; Tao J; Wang L; Zhang Z; Li X; Lu Y
Asian Nurs Res (Korean Soc Nurs Sci); 2024 May; 18(2):178-187. PubMed ID: 38723775
[TBL] [Abstract][Full Text] [Related]
39. Predictive Role of MRI and
Perrone AM; Dondi G; Coe M; Ferioli M; Telo S; Galuppi A; Crescenzo E; Tesei M; Castellucci P; Nanni C; Fanti S; Morganti AG; De Iaco P
Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32178252
[TBL] [Abstract][Full Text] [Related]
40. Longitudinal Effects of Base of Tongue Concurrent Chemoradiation Therapy in a Pre-Clinical Model.
Benedict PA; Kravietz A; Yang J; Achlatis E; Doyle C; Johnson AM; Dion GR; Amin MR
Laryngoscope; 2023 Jun; 133(6):1455-1461. PubMed ID: 36134872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
